لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schenk KM; Department of Oncology, Bozeman Health Deaconess Cancer Center, Bozeman, MT.; Department of Oncology, Johns Hopkins University, Baltimore, MD., Deutsch JS; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Chandra S; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL., Davar D; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA., Eroglu Z; Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, FL., Khushalani NI; Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, FL., Luke JJ; Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA., Ott PA; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA., Sosman JA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL., Aggarwal V; Division of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL., Schollenberger MD; Department of Oncology, Johns Hopkins University, Baltimore, MD., Sharfman WH; Department of Oncology, Johns Hopkins University, Baltimore, MD.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Bibee KP; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD., Scott JF; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD.; Clinical Skin Center of Northern Virginia, Fairfax, VA., Loss MJ; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD., Wang H; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.; Division of Quantitative Sciences, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Qi H; Division of Quantitative Sciences, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Sharon E; National Cancer Institute, Investigational Drug Branch, Cancer Therapy Evaluation Program, Bethesda, MD., Streicher H; National Cancer Institute, Investigational Drug Branch, Cancer Therapy Evaluation Program, Bethesda, MD., Chen HX; National Cancer Institute, Investigational Drug Branch, Cancer Therapy Evaluation Program, Bethesda, MD., Woodward RN; CareDx, Brisbane, CA., Bagnasco SM; Department of Pathology, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Baltimore, MD., Taube JM; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Topalian SL; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD., Brennan DC; Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Lipson EJ; Department of Oncology, Johns Hopkins University, Baltimore, MD.; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 20; Vol. 42 (9), pp. 1011-1020. Date of Electronic Publication: 2024 Jan 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Kidney Transplantation*/adverse effects , Melanoma*/pathology , Cell-Free Nucleic Acids* , Kidney Neoplasms*/pathology, Adult ; Humans ; Nivolumab/therapeutic use ; Ipilimumab/therapeutic use ; Tacrolimus/adverse effects ; Prednisone/therapeutic use ; Prospective Studies ; Creatinine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Deutsch JS; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lai J; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Schenk KM; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Soni A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Will EM; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Engle LL; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Xu H; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ogurtsova A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Madan V; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Chong JK; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wang D; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Green BF; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Nguyen P; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Schollenberger MD; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lipson EJ; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University, Baltimore, Maryland, USA., Taube JM; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jtaube1@jhmi.edu.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University, Baltimore, Maryland, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Dec 14; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 14.

نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Basal Cell*/drug therapy , Skin Neoplasms*/drug therapy, Humans ; B7-H1 Antigen ; Hepatitis A Virus Cellular Receptor 2 ; Programmed Cell Death 1 Receptor ; Tumor Microenvironment

المؤلفون: Pourmaleki M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional Program in Computational Biology and Medicine, Weill Cornell School of Medicine, New York, New York., Jones CJ; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Ariyan CE; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Zeng Z; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Pirun M; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Navarrete DA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Li Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Zhang M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Nandakumar S; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Campos C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Nadeem S; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Klimstra DS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Temple-Oberle CF; Department of Surgery, University of Calgary, Calgary, Alberta, Canada.; Department of Oncology, University of Calgary, Calgary, Alberta, Canada., Brenn T; Department of Pathology, University of Calgary, Calgary, Alberta, Canada., Lipson EJ; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Schenk KM; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Stein JE; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Taube JM; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Traweek R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kirkwood JM; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Gasmi B; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Goff SL; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Corwin AD; Biology and Applied Physics, GE Global Research Center, Niskayuna, New York., McDonough E; Biology and Applied Physics, GE Global Research Center, Niskayuna, New York., Ginty F; Biology and Applied Physics, GE Global Research Center, Niskayuna, New York., Callahan MK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Schietinger A; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.; Immunology and Microbial Pathogenesis Program, Weill Cornell School of Medicine, New York, New York., Socci ND; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Mellinghoff IK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pharmacology, Weill Cornell School of Medicine, New York, New York., Hollmann TJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California.

المصدر: Cancer immunology research [Cancer Immunol Res] 2022 Mar 01; Vol. 10 (3), pp. 303-313.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2*/therapeutic use , Melanoma*/drug therapy , Melanoma*/genetics , Melanoma*/pathology, Hepatitis A Virus Cellular Receptor 2 ; Humans ; Immunotherapy/methods ; Programmed Cell Death 1 Receptor/metabolism

المؤلفون: Giraldo NA; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Berry S; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Becht E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Ates D; Department of Pathology, Hacettepe University, Ankara, Turkey., Schenk KM; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Engle EL; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Green B; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Nguyen P; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Soni A; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Stein JE; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Succaria F; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Ogurtsova A; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Xu H; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Anders RA; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Lipson EJ; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Danilova L; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Baras AS; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Taube JM; Department of Pathology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland. jtaube1@jhmi.edu.; Department of Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and The Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.; Department of Dermatology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.

المصدر: Cancer immunology research [Cancer Immunol Res] 2021 Nov; Vol. 9 (11), pp. 1262-1269. Date of Electronic Publication: 2021 Aug 25.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*immunology , Image Cytometry/*methods , Proteomics/*methods , Tumor Microenvironment/*immunology, Humans

المؤلفون: Gable DL; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Telomere Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Gaysinskaya V; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Telomere Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Atik CC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Telomere Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Talbot CC Jr; Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA., Kang B; Department of Comparative and Molecular Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Stanley SE; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Telomere Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Pugh EW; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Amat-Codina N; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Telomere Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Schenk KM; Osler Medical Housestaff Training Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA., Arcasoy MO; Department of Medicine, Duke University School of Medicine, Durham, North Carolina 27708, USA., Brayton C; Department of Comparative and Molecular Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Florea L; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA., Armanios M; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Telomere Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

المصدر: Genes & development [Genes Dev] 2019 Oct 01; Vol. 33 (19-20), pp. 1381-1396. Date of Electronic Publication: 2019 Sep 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 8711660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-5477 (Electronic) Linking ISSN: 08909369 NLM ISO Abbreviation: Genes Dev Subsets: MEDLINE

مواضيع طبية MeSH: Loss of Function Mutation*, Carrier Proteins/*genetics , Idiopathic Pulmonary Fibrosis/*genetics , Nuclear Proteins/*genetics , RNA/*metabolism , Telomerase/*metabolism, Animals ; Brain/enzymology ; Brain/physiopathology ; Cell Line ; Cilia/genetics ; Female ; Genetic Linkage ; HCT116 Cells ; Humans ; Idiopathic Pulmonary Fibrosis/enzymology ; Idiopathic Pulmonary Fibrosis/physiopathology ; Male ; Mice ; Mice, Knockout ; Neurodevelopmental Disorders/genetics ; Pedigree ; RNA Processing, Post-Transcriptional/genetics ; Telomere Shortening/genetics

المؤلفون: Schenk KM; Johns Hopkins School of Medicine, Baltimore, Maryland., Reuss JE; Johns Hopkins School of Medicine, Baltimore, Maryland., Choquette K; Virginia Cancer Specialists (VCS), Fairfax, Virginia.; US Oncology Research, The Woodlands, Texas, USA., Spira AI; Johns Hopkins School of Medicine, Baltimore, Maryland.; Virginia Cancer Specialists (VCS), Fairfax, Virginia.; US Oncology Research, The Woodlands, Texas, USA.

المصدر: Anti-cancer drugs [Anticancer Drugs] 2019 Oct; Vol. 30 (9), pp. 879-885.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*pharmacology , Antibodies, Monoclonal, Humanized/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy, Animals ; Carcinoma, Non-Small-Cell Lung/metabolism ; Humans ; Incidence ; Inflammation/metabolism ; Interleukin-1beta/metabolism ; Lung Neoplasms/metabolism ; Neoplasm Recurrence, Local/metabolism